Results 221 to 230 of about 960,477 (390)
Molecular Oncology, EarlyView.In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton +17 more
wiley +1 more source
Centres for treatment of drug addiction. Treatment in the community. [PDF]
, 1967 P. A. L. Chapple
openalex +1 more source
Molecular Oncology, EarlyView.Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop +10 more
wiley +1 more source
Diagnosis of Amphetamine Addiction [PDF]
, 1965 John C. Johnson, George R. Milner
openalex +3 more sources
Molecular Oncology, EarlyView.Trastuzumab‐deruxtecan, a HER2‐targeting antibody‐drug conjugate, shows promising antitumor activity in head and neck squamous cell carcinoma with low HER2 expression. In vitro and in vivo studies demonstrated dose‐dependent cell death and tumor growth reduction in low HER2‐expressing cell lines, which correlated with drug accumulation measured using a
Abdullah Bin Naveed +8 more
wiley +1 more source
From eveningness to food addiction: exploring the roles of night eating syndrome and mindful eating. [PDF]
J Eat DisordBaşar Gökcen B.
europepmc +1 more source
Heroin addiction in the United Kingdom (1954-1964). [PDF]
, 1965 T. H. Bewley
openalex +1 more source